Funding for this research was provided by:
National Cancer Institute (R01CA231099)
Received: 6 March 2019
Accepted: 7 August 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: The animal study (protocol number 1701) was approved by the University of Missouri-Kansas City, Institutional Animal Care and Use Committee (IACUC).
: Not applicable.
: We are in the process of filing a patent for the anti-PD-L1 peptides discovered in this study.